Disease/Infection News

RSS

Age-stratified analysis of COVID-19 severity outcomes among vaccinees and individuals with prior SARS-CoV-2 exposure in Indiana

Researchers assessed the effectiveness of vaccine-conferred immune protection against novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, any-cause visits to hospitals and emergency departments (ED), and deaths in Indiana.

21 Dec 2022

ACAAI’s two new yardsticks on managing eosinophilic esophagitis and cough published

Beginning in 2016, the American College of Allergy, Asthma and Immunology (ACAAI) began developing a series of yardsticks to help practitioners better understand the range of treatments available for allergic conditions.

21 Dec 2022

Clinical trials demonstrate safety and efficacy of Ebola Zaire vaccines

Two vaccines against the Zaire strain of Ebola virus are immunogenic and safe in both adults and children, according to initial results from two phase II clinical trials published in the New England Journal of Medicine.

21 Dec 2022

MHRA authorizes the COVID-19 vaccine developed by Sanofi

VidPrevtyn Beta, the COVID-19 vaccine developed by Sanofi, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).

21 Dec 2022

Exploring environmental viral emissions after SARS-CoV-2 Human challenge

A recent study captured the dynamics of pre-symptomatic SARS-CoV-2 emissions and reported the extent, magnitude, and routes of viral transmission are heterogeneous, with nasal mucosa being an important source of viral transmission.

21 Dec 2022

SILVER Study provides insight into the challenges presented by COVID-19 to older New Yorkers

ICAP at Columbia University Mailman School of Public Health has released results from Round Two of the SILVER Study, providing insight into the challenges presented by COVID-19 to older adults living at home in New York City.

20 Dec 2022

Findings on the origins of the SARS-CoV-2 variant Omicron retracted

On December 1, Charité – Universitätsmedizin Berlin reported new findings on the origins of the SARS-CoV-2 variant Omicron.

20 Dec 2022

Study examines the association of dementia diagnosis with risk of COVID-19 mortality

Since December 2019, more than 60 million people have been diagnosed with coronavirus disease 2019 (COVID-19) worldwide, while approximately six million individuals have died as a result of the disease.

20 Dec 2022

Trial of three vaccines for Zaire Ebola virus disease

Researchers perform two randomized controlled trials to determine immunogenicity and safety of three Ebola vaccines.

20 Dec 2022

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination

Researchers report the frequencies of novel POTS-related diagnoses prior to and after SARS-CoV-2 infection and COVID-19 vaccination.

20 Dec 2022

South Korean parents' attitudes and perceptions towards child COVID-19 vaccination

Researchers assess how the credibility of information provided on COVID-19 vaccines were associated with parental attitudes toward vaccinating their children.

20 Dec 2022

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Researchers assessed the impact of ivermectin on the duration of sustained recovery among coronavirus disease 2019 (COVID-19) outpatients.

20 Dec 2022

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

Researchers from Germany conducted a population-based surveillance study to ascertain the etiology of community acquired pneumonia (CAP) during the re-emergence of viral and bacterial respiratory diseases after the relaxation of coronavirus disease 2019 (COVID-19) containment and mitigation measures.

20 Dec 2022

COVID-19 epidemiology can be estimated using blood donation samples

An article published in the journal eLife reports a study in which researchers concluded that the proportion of the population previously infected by SARS-CoV-2 (infection-induced seroprevalence) can be estimated using blood donation samples.

20 Dec 2022

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

A study describes the antiviral activity of flavor/fragrance compositions against SARS-CoV-2.

20 Dec 2022

The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England

Researchers assessed the effects of two-dose COVID-19 vaccinations on household SARS-CoV-2 transmission among British residents.

20 Dec 2022

SARS-CoV-2 structural proteins trigger periodontal fibrosis

Researchers examined the pathological impacts of the structural components of SARS-CoV-2 on human periodontal cells and tissue to understand the association between coronavirus disease 2019 (COVID-19) and deteriorating oral health.

20 Dec 2022

Seroprevalence measurements reveal a higher incidence of asymptomatic SARS-CoV-2 infections among residents of three federal German states

Researchers measured the seroprevalence against SARS-CoV-2 in blood donors from the states of Hesse, Lower Saxony, and North Rhine-Westphalia in Germany to determine the incidence of undetected asymptomatic SARS-CoV-2 infections.

20 Dec 2022

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

Researchers compared the prognosis of myocarditis developing after BNT162b2 mRNA COVID-19 vaccination with viral myocarditis over six months.

20 Dec 2022

Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein

Researchers developed a measles virus (MeV)-vectored vaccine capable of inducing high neutralizing antibody (nAb) responses against SARS-CoV-2.

20 Dec 2022

Disease/Infection News

Age-stratified analysis of COVID-19 severity outcomes among vaccinees and individuals with prior SARS-CoV-2 exposure in Indiana

ACAAI’s two new yardsticks on managing eosinophilic esophagitis and cough published

Clinical trials demonstrate safety and efficacy of Ebola Zaire vaccines

MHRA authorizes the COVID-19 vaccine developed by Sanofi

Exploring environmental viral emissions after SARS-CoV-2 Human challenge

SILVER Study provides insight into the challenges presented by COVID-19 to older New Yorkers

Findings on the origins of the SARS-CoV-2 variant Omicron retracted

Study examines the association of dementia diagnosis with risk of COVID-19 mortality

Trial of three vaccines for Zaire Ebola virus disease

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination

South Korean parents' attitudes and perceptions towards child COVID-19 vaccination

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

COVID-19 epidemiology can be estimated using blood donation samples

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England

SARS-CoV-2 structural proteins trigger periodontal fibrosis

Seroprevalence measurements reveal a higher incidence of asymptomatic SARS-CoV-2 infections among residents of three federal German states

Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis

Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News